Pupillary Pathways

Follow Us

FDA Approves Avaclyr® for the Treatment of Herpes Simplex Dendritic Keratitis

Posted by Amanda Dexter on Apr 15, 2019 12:00:00 AM
 
On March 29, 2019, the U.S. Food and Drug Administration approved a new topical ophthalmic medication known as Avaclyr ® for the treatment of herpes simplex dendritic keratitis.
Read More
0 Comments Click here to read/write comments

Topics: Drug Updates

All posts

 

 

Popular Posts

Posts by Topic

see all

Support  ·   FAQ  ·   Authors  ·   Student Representatives  ·   References  ·   Terms & Conditions  ·   Contact

NBEO® is a registered trademark owned by the National Board of Examiners in Optometry. This web site is not licensed by, endorsed by, or affiliated with the National Board of Examiners in Optometry.

© 2017 OptoPrep.com · All rights reserved.